| scholarly article | Q13442814 |
| P2093 | author name string | J E Oakes | |
| R N Lausch | |||
| P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
| Lymphocyte reactivity contributes to protection conferred by specific antibody passively transferred to herpes simplex virus-infected mice | Q33906859 | ||
| Role for cell-mediated immunity in the resistance of mice to subcutaneous herpes simplex virus infection | Q34123889 | ||
| Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra-axonal transport of infection | Q34483710 | ||
| THE PATHOGENESIS OF HERPES VIRUS ENCEPHALITIS. I. VIRUS PATHWAYS TO THE NERVOUS SYSTEM OF SUCKLING MICE DEMONSTRATED BY FLUORESCENT ANTIBODY STAINING | Q36266931 | ||
| Deficiency of the fifth component of complement in mice with an inherited complement defect | Q36268719 | ||
| Proteins specified by herpes simplex virus. II. Viral glycoprotins associated with cellular membranes | Q37138787 | ||
| Inhibition or Enhancement of Immunological Injury of Virus-Infected Cells | Q37494235 | ||
| The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. II. Identification as a K cell | Q39423013 | ||
| Invasion of the Central Nervous System by Herpes Simplex Virus Type 1 after Subcutaneous Inoculation of Immunosuppressed Mice | Q39916870 | ||
| Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection | Q39968639 | ||
| Host defenses in herpes simplex infections of the nervous system: effect of antibody on disease and viral spread | Q40210961 | ||
| Evaluation of survival in challenge experiments | Q40270509 | ||
| Ocular Infection with Herpes Simplex Virus Type 1: Prevention of Acute Herpetic Encephalitis by Systemic Administration of Virus-Specific Antibody | Q40275248 | ||
| Mechanism of Acquired Resistance to Herpes Simplex Virus Infection as Studied in Nude Mice | Q40286224 | ||
| Antibody-mediated recovery from subcutaneous herpes simplex virus type 2 infection | Q40911362 | ||
| Murine antibody-dependent cellular cytotoxicity to herpes simplex virus-infected target cells | Q41633180 | ||
| THE CATABOLISM OF HOMOLOGOUS AND HETEROLOGOUS 7S GAMMA GLOBULIN FRAGMENTS | Q42829667 | ||
| Mechanism of recovery from systemic herpes simplex virus infection. I. Comparative effectiveness of antibody and reconstitution of immune spleen cells on immunosuppressed mice | Q45793552 | ||
| Detection of cell-dependent cytotoxic antibody to cells infected with herpes simplex virus | Q45817934 | ||
| The proteins specified by herpes simplex virus. I. Time of synthesis, transfer into nuclei, and properties of proteins made in productively infected cells | Q45823492 | ||
| Heterogeneity in the properties of 7 S and 19S rabbit-neutralizing antibodies to herpes simplex virus. | Q45823923 | ||
| Study of Fab and F(ab′)2 from Rabbit IgG for Capacity to Induce Lymphocyte-Mediated Target Cell Destruction <i>in vitro</i> | Q69238332 | ||
| Separation of univalent fragments from the bivalent rabbit antibody molecule by reduction of disulfide bonds | Q78847739 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 109-114 | |
| P577 | publication date | 1981-07-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Role of Fc fragments in antibody-mediated recovery from ocular and subcutaneous herpes simplex virus infections | |
| P478 | volume | 33 |
| Q36831366 | A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G. |
| Q27486833 | Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing) |
| Q36740192 | Antibody-mediated protection against genital herpes simplex virus type 2 disease in mice by Fc gamma receptor-dependent and -independent mechanisms |
| Q41900199 | Direct evidence for antibody bipolar bridging on herpes simplex virus-infected cells |
| Q37456642 | Herpes simplex virus as a tool to define the role of complement in the immune response to peripheral infection |
| Q36829124 | Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity |
| Q45324845 | Highly Efficacious Novel Vaccine, Humoral Immunity, and Ocular Herpes Simplex Virus 1: Reality or Myth? |
| Q36955074 | Immunization strategies to block the herpes simplex virus type 1 immunoglobulin G Fc receptor |
| Q36917531 | Immunogenicity of herpes simplex virus glycoproteins gC and gB and their role in protective immunity |
| Q39726771 | Immunologic basis for increased susceptibility of the neonate to infection |
| Q45799569 | Mechanism of Antibody-Mediated Protection against Herpes Simplex Virus Infection in Athymic Nude Mice: Requirement of Fc Portion of Antibody |
| Q36333640 | Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2 |
| Q36892657 | Protection against lethal viral infection by neutralizing and nonneutralizing monoclonal antibodies: distinct mechanisms of action in vivo |
| Q44298487 | Protective effects of anti-glycoprotein D monoclonal antibodies in murine herpetic keratitis |
| Q27486933 | Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies |
| Q72936137 | Studies on the Interrelation of Resistance and Immunity in a Mouse Model System of Herpes-Simplex Type 2 Infection |
| Q34212487 | The antiviral activity of antibodies in vitro and in vivo. |
| Q72712733 | The biological properties of immunoglobulin G and its split products [F(ab')2 and Fab] |
| Q36335255 | Use of monoclonal antibodies for analysis of antibody-dependent immunity to ocular herpes simplex virus type 1 infection |
Search more.